FDA clears Abbott glucose-monitoring tool

The FDA has granted Abbott Laboratories approval to market its FreeStyle Navigator system, designed to continuously monitor the blood-sugar levels of diabetics. The device, which was cleared by European regulators last June, will be available in the second quarter of 2008 by prescription.

View Full Article in:

Chicago Sun-Times (free registration) · Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ